Phase separation enhances probability of receptor signalling and drug targeting

John E Ladbury1, Chi-Chuan Lin1, Kin Man Suen1

  • 1School of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK.

Insights

Receptor tyrosine kinase (RTK) signaling is often unreliable due to molecular noise. Intracellular liquid-liquid phase separation (LLPS) helps ensure specific cellular outcomes by organizing signaling molecules at the plasma membrane.

Area of Science:

  • Cellular Biology
  • Biochemistry
  • Signal Transduction

Background:

  • Receptor tyrosine kinase (RTK) signaling pathways are crucial for cellular functions but are inherently probabilistic.
  • Low signaling efficiency results from molecular diffusion, promiscuous interactions, and background cellular noise.
  • Achieving specific cellular outcomes requires overcoming these challenges to form functional signaling complexes.

Purpose of the Study:

  • To investigate the role of intracellular liquid-liquid phase separation (LLPS) in enhancing the fidelity of RTK signaling.
  • To understand how LLPS contributes to overcoming the probabilistic nature of signal transduction.
  • To explore the mechanism by which LLPS promotes discrete cellular outcomes and signal exclusivity.

Main Methods:

  • The study likely involves in vitro reconstitution assays or live-cell imaging to observe RTK signaling dynamics.
  • Computational modeling may be used to simulate molecular diffusion and complex formation.
  • Biochemical techniques could be employed to analyze protein interactions and phase separation phenomena.

Main Results:

  • LLPS at the plasma membrane concentrates signaling molecules, increasing the probability of functional complex formation.
  • Phase separation effectively reduces the impact of background noise and random molecular events.
  • This mechanism promotes the initiation of specific signaling pathways while excluding others, ensuring signal fidelity.

Conclusions:

  • Intracellular liquid-liquid phase separation (LLPS) acts as a critical mechanism to enhance the reliability of receptor tyrosine kinase (RTK) signaling.
  • LLPS provides a physical basis for overcoming the probabilistic challenges inherent in cellular signal transduction.
  • This process ensures that specific cellular outcomes are achieved with greater certainty and mutual exclusivity.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.6K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
2.0K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
243
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
7.2K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.5K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
3.0K